Drugs / OTO-201
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01755286 | Dec 2012 → Jun 2013 | otitis media with effusion | Otonomy, Inc. | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02511561 | Jul → Nov 2015 | otitis externa | Otonomy, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02408796 | Mar → May 2015 | otitis media | Otonomy, Inc. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02350998 | Jan → Mar 2015 | otitis media with effusion | Otonomy, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OTO-201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02350998 ↗ |
| Known as | ciprofloxacin | “OTO-201 (ciprofloxacin)” NCT02511561 ↗ |
| Route | Other | “OTO-201 Given as a Single Intratympanic Injection” NCT01755286 ↗ |